Targeting the DNA Repair Enzyme Polymerase θ in Cancer Therapy

被引：108
|
作者：
Schrempf, Anna [1 ,2 ]
Slyskova, Jana [1 ,2 ]
Loizou, Joanna, I [1 ,2 ]
机构：
[1] Austrian Acad Sci, CeMM Res Ctr Mol Med, Lazarettgasse 14,AKH BT 25-3, A-1090 Vienna, Austria
[2] Med Univ Vienna, Comprehens Canc Ctr, Inst Canc Res, Dept Med 1, A-1090 Vienna, Austria
来源：
TRENDS IN CANCER | 2021年 / 7卷 / 02期
基金：
欧洲研究理事会;
关键词：
DOUBLE-STRAND BREAKS; BASE EXCISION-REPAIR; HOMOLOGOUS-RECOMBINATION; POL-THETA; LIGASE-III; HELICASE DOMAIN; CELLS; RESISTANCE; TUMORS; BYPASS;
D O I：
10.1016/j.trecan.2020.09.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Targeted cancer therapies represent a milestone towards personalized treatment as they function via inhibition of cancer-specific alterations. Polymerase theta (POLQ), an error-prone translesion polymerase, also involved in DNA double-strand break (DSB) repair, is often upregulated in cancer. POLQ is synthetic lethal with various DNA repair genes, including known cancer drivers such as BRCA1/2, making it essential in homologous recombination-deficient cancers. Thus, POLQ represents a promising target in cancer therapy and efforts for the development of POLQ inhibitors are actively underway with first clinical trials due to start in 2021. This review summarizes the journey of POLQ from a backup DNA repair enzyme to a promising therapeutic target for cancer treatment.
引用
收藏
页码：98 / 111
页数：14
相关论文
共 50 条
  • [21] Targeting mRNA methyltransferase in RNA-dependent DNA repair in cancer therapy
    Lan, Li
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (11)
  • [22] Targeting DNA damage and repair: Embracing the pharmacological era for successful cancer therapy
    Aziz, K.
    Nowsheen, S.
    Pantelias, G.
    Iliakis, G.
    Gorgoulis, V. G.
    Georgakilas, A. G.
    PHARMACOLOGY & THERAPEUTICS, 2012, 133 (03) : 334 - 350
  • [23] Targeting DNA repair: poly (ADP-ribose) polymerase inhibitors
    Frey, Melissa K.
    Pothuri, Bhavana
    TRANSLATIONAL CANCER RESEARCH, 2015, 4 (01) : 84 - 96
  • [24] Targeting DNA repair defects in prostate cancer
    Thoma, Clemens
    NATURE REVIEWS UROLOGY, 2020, 17 (08) : 432 - 432
  • [25] Targeting DNA repair defects in prostate cancer
    Clemens Thoma
    Nature Reviews Urology, 2020, 17 : 432 - 432
  • [26] Targeting defective DNA repair in prostate cancer
    Carmichael, Juliet
    Maza, Maria de los Dolores Fenor de la
    Rescigno, Pasquale
    Chandran, Khobe
    de Bono, Johann
    CURRENT OPINION IN ONCOLOGY, 2020, 32 (05) : 503 - 509
  • [27] Epigenetic targeting of DNA repair in lung cancer
    Lok, Benjamin H.
    Rudin, Charles M.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (45) : 22429 - 22431
  • [28] Targeting DNA repair proteins for cancer treatment
    Gianluca Tell
    David M. Wilson
    Cellular and Molecular Life Sciences, 2010, 67 : 3569 - 3572
  • [29] Targeting DNA Repair: Beyond Cancer.
    Helleday, T.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2019, 60 : 44 - 45
  • [30] Targeting DNA repair proteins for cancer treatment
    Tell, Gianluca
    Wilson, David M., III
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2010, 67 (21) : 3569 - 3572
12345